Tissue-Engineered Urinary Conduits

Max Kates, Anirudha Singh, Hotaka Matsui, Gary D. Steinberg, Norm D. Smith, Mark P. Schoenberg, Trinity J. Bivalacqua

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The role of tissue engineering in the cystectomy population rests on the principle of sparing healthy intestinal tissue while replacing diseased bladder. Over the last 25 years advances in cell biology and material science have improved the quality and durability of bladder replacement in animals. The neo-urinary conduit ([NUC]-Tengion) employs autologous fat smooth muscle cells which are seeded onto synthetic, biodegradable scaffolds. This seeded construct is then implanted in the patient and purportedly regenerates native urinary tissue to serve as a passive channel connecting the ureters to the skin surface. Preclinical animal studies as well as the first phase I human trial implanting the NUC are reviewed. While the ultimate goal of creating a durable, effective, tissue-engineered conduit is still in its infancy, important technical and experimental strides have been made.

Original languageEnglish (US)
JournalCurrent Urology Reports
Volume16
Issue number3
DOIs
StatePublished - 2015

Fingerprint

Urinary Bladder Diseases
Cystectomy
Tissue Engineering
Ureter
Smooth Muscle Myocytes
Cell Biology
Urinary Bladder
Fats
Skin
Population

Keywords

  • Cystectomy population
  • Phase I human trial implanting
  • Tissue engineering
  • Urinary conduits

ASJC Scopus subject areas

  • Urology

Cite this

Kates, M., Singh, A., Matsui, H., Steinberg, G. D., Smith, N. D., Schoenberg, M. P., & Bivalacqua, T. J. (2015). Tissue-Engineered Urinary Conduits. Current Urology Reports, 16(3). https://doi.org/10.1007/s11934-015-0480-3

Tissue-Engineered Urinary Conduits. / Kates, Max; Singh, Anirudha; Matsui, Hotaka; Steinberg, Gary D.; Smith, Norm D.; Schoenberg, Mark P.; Bivalacqua, Trinity J.

In: Current Urology Reports, Vol. 16, No. 3, 2015.

Research output: Contribution to journalArticle

Kates, M, Singh, A, Matsui, H, Steinberg, GD, Smith, ND, Schoenberg, MP & Bivalacqua, TJ 2015, 'Tissue-Engineered Urinary Conduits', Current Urology Reports, vol. 16, no. 3. https://doi.org/10.1007/s11934-015-0480-3
Kates, Max ; Singh, Anirudha ; Matsui, Hotaka ; Steinberg, Gary D. ; Smith, Norm D. ; Schoenberg, Mark P. ; Bivalacqua, Trinity J. / Tissue-Engineered Urinary Conduits. In: Current Urology Reports. 2015 ; Vol. 16, No. 3.
@article{74c993ec32f24085b9ba8bb4fbf88a04,
title = "Tissue-Engineered Urinary Conduits",
abstract = "The role of tissue engineering in the cystectomy population rests on the principle of sparing healthy intestinal tissue while replacing diseased bladder. Over the last 25 years advances in cell biology and material science have improved the quality and durability of bladder replacement in animals. The neo-urinary conduit ([NUC]-Tengion) employs autologous fat smooth muscle cells which are seeded onto synthetic, biodegradable scaffolds. This seeded construct is then implanted in the patient and purportedly regenerates native urinary tissue to serve as a passive channel connecting the ureters to the skin surface. Preclinical animal studies as well as the first phase I human trial implanting the NUC are reviewed. While the ultimate goal of creating a durable, effective, tissue-engineered conduit is still in its infancy, important technical and experimental strides have been made.",
keywords = "Cystectomy population, Phase I human trial implanting, Tissue engineering, Urinary conduits",
author = "Max Kates and Anirudha Singh and Hotaka Matsui and Steinberg, {Gary D.} and Smith, {Norm D.} and Schoenberg, {Mark P.} and Bivalacqua, {Trinity J.}",
year = "2015",
doi = "10.1007/s11934-015-0480-3",
language = "English (US)",
volume = "16",
journal = "Current Urology Reports",
issn = "1527-2737",
publisher = "Current Science, Inc.",
number = "3",

}

TY - JOUR

T1 - Tissue-Engineered Urinary Conduits

AU - Kates, Max

AU - Singh, Anirudha

AU - Matsui, Hotaka

AU - Steinberg, Gary D.

AU - Smith, Norm D.

AU - Schoenberg, Mark P.

AU - Bivalacqua, Trinity J.

PY - 2015

Y1 - 2015

N2 - The role of tissue engineering in the cystectomy population rests on the principle of sparing healthy intestinal tissue while replacing diseased bladder. Over the last 25 years advances in cell biology and material science have improved the quality and durability of bladder replacement in animals. The neo-urinary conduit ([NUC]-Tengion) employs autologous fat smooth muscle cells which are seeded onto synthetic, biodegradable scaffolds. This seeded construct is then implanted in the patient and purportedly regenerates native urinary tissue to serve as a passive channel connecting the ureters to the skin surface. Preclinical animal studies as well as the first phase I human trial implanting the NUC are reviewed. While the ultimate goal of creating a durable, effective, tissue-engineered conduit is still in its infancy, important technical and experimental strides have been made.

AB - The role of tissue engineering in the cystectomy population rests on the principle of sparing healthy intestinal tissue while replacing diseased bladder. Over the last 25 years advances in cell biology and material science have improved the quality and durability of bladder replacement in animals. The neo-urinary conduit ([NUC]-Tengion) employs autologous fat smooth muscle cells which are seeded onto synthetic, biodegradable scaffolds. This seeded construct is then implanted in the patient and purportedly regenerates native urinary tissue to serve as a passive channel connecting the ureters to the skin surface. Preclinical animal studies as well as the first phase I human trial implanting the NUC are reviewed. While the ultimate goal of creating a durable, effective, tissue-engineered conduit is still in its infancy, important technical and experimental strides have been made.

KW - Cystectomy population

KW - Phase I human trial implanting

KW - Tissue engineering

KW - Urinary conduits

UR - http://www.scopus.com/inward/record.url?scp=84923112999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923112999&partnerID=8YFLogxK

U2 - 10.1007/s11934-015-0480-3

DO - 10.1007/s11934-015-0480-3

M3 - Article

VL - 16

JO - Current Urology Reports

JF - Current Urology Reports

SN - 1527-2737

IS - 3

ER -